Brainsway Ltd. - Regulatory Filings 2021

BrainsWay Announces First of its Kind Coverage Policy by Centene for the Treatment of OCD Utilizing Deep TMS false


	Israel Securities Authority			Tel Aviv Stock Exchange		C002 ( Public )		Reported via MAGNA:	24/05/2021
	www.isa.gov.il			www.tase.co.il				Reference:	2021-02-088803	Time of broadcast: 11:43 11:43

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000


	The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report onBrainsWay Announces First of its Kind Coverage Policy by Centene for the Treatment of OCD Utilizing Deep TMS

BrainsWay_Announces_First_of_its_Kind_Coverage_Policy_by_Centene_for_the_Treatment_of_OCD_Utilizing_Deep_TMS_isa.pdf



References of previous documents relating to this matter(the reference does not constitute incorporation by reference):


- - -
Stock Exchange/Market: BWAY	Date of revision of form structure: 04/05/2021
Address: �� 19 , �� 91451 , Tel: 02-5813140 , Fax: 02-5812517
E-mail address: [email protected] Company site: www.Brainsway.com

Previous names of reporting entity:

Name of the Signatory: Levy Hadar Position of Signatory in the reporting corporation: Chief Financial Officer Name of Employer Company:
Address: Hartum Street, Bynet Building 19 , Jerusalem 9777518 Telephone: 97225824030 Facsimile: 97225812517 E-mail: [email protected] 1

AI assistant